US Senator

Roger Marshall 2023-2024 Regular Session - Authored & Sponsored Legislation (Page 23)

Legislative Session

Co-Sponsor of Legislation

US

Us Congress 2023-2024 Regular Session

Us Congress Senate Bill SB783

Introduced
3/14/23  
GAS PRICE Act Give Americans Stability at Pumps as Rising Inflation Causes Emergencies Act
US

Us Congress 2023-2024 Regular Session

Us Congress Senate Bill SB785

Introduced
3/14/23  
Consumer and Fuel Retailer Choice Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress Senate Bill SB786

Introduced
3/14/23  
PHIT Act of 2023 Personal Health Investment Today Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress Senate Bill SB788

Introduced
3/14/23  
Refer
3/14/23  
Engrossed
8/4/23  
Enrolled
12/19/23  
Passed
12/19/23  
Chaptered
12/19/23  
Duck Stamp Modernization Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress Senate Bill SB80

Introduced
1/25/23  
This bill requires the President to appoint an Inspector General of the National Institutes of Health.
US

Us Congress 2023-2024 Regular Session

Us Congress Senate Bill SB813

Introduced
3/15/23  
Expanding Local Meat Processing Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress Senate Bill SB827

Introduced
3/15/23  
A bill to provide that no Federal funds may be used to implement, administer, or enforce the rule of the Department of Justice entitled "Factoring Criteria for Firearms with Attached 'Stabilizing Braces'".
US

Us Congress 2023-2024 Regular Session

Us Congress Senate Bill SB834

Introduced
3/16/23  
ACE Agriculture Act of 2023 Advancing Cutting Edge Agriculture Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress Senate Bill SB84

Introduced
1/25/23  
Defund EcoHealth Alliance Act This bill prohibits the award of federal funds to EcoHealth Alliance, Inc (including any subsidiaries or related organizations). This is a nonprofit research organization that studies coronaviruses in bat populations and other environmental health concerns. The Government Accountability Office must also audit federal funds provided to that organization over the past decade. The audit must include the amount of those funds provided by EcoHealth Alliance to China, the Chinese Communist Party, or the Wuhan Institute of Virology.
US

Us Congress 2023-2024 Regular Session

Us Congress Senate Bill SB866

Introduced
3/16/23  
American Innovation and Jobs Act
US

Us Congress 2023-2024 Regular Session

Us Congress Senate Bill SB9

Introduced
1/23/23  
Protecting America's Strategic Petroleum Reserve from China Act This bill prohibits the sale and export of crude oil from the Strategic Petroleum Reserve (SPR) to China. Specifically, the bill prohibits the Department of Energy (DOE) from selling petroleum products (e.g., crude oil) from the SPR to any entity that is under the ownership, control, or influence of the Chinese Communist Party. Further, DOE must require as a condition of any sale of crude oil from the SPR that the oil not be exported to China.
US

Us Congress 2023-2024 Regular Session

Us Congress Senate Bill SB908

Introduced
3/22/23  
A bill to oppose the provision of assistance to the People's Republic of China by the multilateral development banks.
US

Us Congress 2023-2024 Regular Session

Us Congress Senate Bill SB91

Introduced
1/26/23  
Refer
1/26/23  
Forgotten Heroes of the Holocaust Congressional Gold Medal Act
US

Us Congress 2023-2024 Regular Session

Us Congress Senate Bill SB915

Introduced
3/22/23  
A bill to require Presidential appointment and Senate confirmation of the Inspector General of the Board of Governors of the Federal Reserve System and the Bureau of Consumer Financial Protection.

Primary Sponsor of Legislation

US

Us Congress 2023-2024 Regular Session

Us Congress Senate Bill SB81

Viral Gain-of-Function Research Moratorium Act This bill prohibits the award of federal research grants to institutions of higher education or research institutes that conduct gain-of-function research. Gain-of-function research refers to any research that (1) could confer attributes to influenza, MERS, or SARS viruses such that the virus would have enhanced pathogenicity or transmissibility in an organism; or (2) involves methods that could enhance potential pandemic pathogens or related risky research with potentially dangerous pathogens.